Reversal of Abnormal CD4+ T Cell Metabolism Alleviates Thyroiditis by Deactivating the mTOR/HIF1a/Glycolysis Pathway.

Reversal of Abnormal CD4+ T Cell Metabolism Alleviates Thyroiditis by Deactivating the mTOR/HIF1a/Glycolysis Pathway.
复制标题

逆转异常 CD4 T 细胞代谢,通过停用 mTOR/HIF1a/糖酵解途径缓解甲状腺炎

DOI:
10.3389/fendo.2021.659738
复制
发表时间:
2021
影响因子:
5.2
通讯作者:
Teng W
Teng W
中科院分区:
医学2区
文献类型:
--
作者:
Zhao L;Wu Q;Wang X;Wang S;Shi X;Shan Z;Teng W

文献摘要

参考文献

被引文献

相似文献

桥本甲状腺炎(HT)是一种自身免疫性疾病,其特征是甲状腺抗原特异性辅助T细胞活化。HT患者Th 1和Th 17 T细胞亚群增加。糖酵解支持Th 1和Th 17 T细胞的慢性激活,但这如何有助于HT仍然未知。通过测定细胞外酸化率(ECAR)和耗氧率(OCR),对30例HT患者和30例健康对照者的CD 4 + T细胞代谢进行了评价。亚急性甲状腺炎(SAT)模型中的小鼠接受2DG、二甲双胍或联合给药。Western blot和Seahorse法检测mTOR/HIF-1α/HK 2/糖酵解的表达。采用流式细胞术和HE染色检测SAT的严重程度。HT患者的CD 4 + T细胞ECAR和OCR增强。培养的HT CD 4 + T细胞中Glut 1、HK 2、PKM 2和LDHA水平升高。与对照组相比,培养的SAT CD 4 + T细胞中HK 2和PKM 2的表达升高。mTOR和HIF-1α通路在SAT小鼠中活化显著,2DG处理组中HIF-1α表达降低。2DG和/或二甲双胍治疗显着降低了Th 17和Th 1 T细胞的比例。甲状腺炎导致CD 4 + T细胞中mTOR/HIF-1α/HK 2/糖酵解途径升高。2DG和二甲双胍治疗可降低该途径的激活,也可逆转CD 4 + T细胞分化的失衡。
Hashimoto’s thyroiditis (HT) is an autoimmune disease that features activation of thyroid antigen-specific helper T cells. HT patients have increased Th1 and Th17 T cell subsets. Glycolysis supports chronic activation of Th1 and Th17 T cells, but how this contributes to HT remains unknown. The metabolism of CD4+ T cells from 30 HT patients and 30 healthy controls was evaluated by determining the extracellular acidification rate (ECAR) and the oxygen consumption rate (OCR). Mice in a subacute thyroiditis (SAT) model were treated with 2DG, metformin, or combination. Metrics of mTOR/HIF-1α/HK2/glycolysis were measured by western blot and Seahorse assay methods. The severity of SAT was measured by flow cytometry and HE staining. CD4+ T cells from HT patients had enhanced ECAR and OCR. Levels of Glut1, HK2, PKM2, and LDHA in cultured HT CD4+ T cells were elevated. The expression of HK2 and PKM2 in cultured SAT CD4+ T cells was elevated compared with the control group. Activation of the mTOR and HIF-1α pathways was significant in SAT mice, and expression of HIF-1α in the 2DG treated group was reduced. Treatment with 2DG and/or metformin significantly decreased the ratio of Th17 and Th1 T cells. Thyroiditis results in elevation of the mTOR/HIF-1α/HK2/glycolysis pathway in CD4+ T cells. The activation of this pathway is reduced by treatment with 2DG and metformin, which also reverted imbalances in CD4+ T cell differentiation.
DOI: 10.1038/nature04753
发表时间: 2006-05-11
期刊: NATURE
影响因子: 64.8
作者:
Bettelli, E;Carrier, YJ;Kuchroo, VK
通讯作者: Kuchroo, VK
DOI: 10.1016/j.immuni.2015.02.002
发表时间: 2015-03-17
期刊: IMMUNITY
影响因子: 32.4
作者:
Weinberg, Samuel E.;Sena, Laura A.;Chandel, Navdeep S.
通讯作者: Chandel, Navdeep S.
DOI: 10.1016/j.cell.2011.07.033
发表时间: 2011-09-02
期刊: Cell
影响因子: 64.5
作者:
Dang EV;Barbi J;Yang HY;Jinasena D;Yu H;Zheng Y;Bordman Z;Fu J;Kim Y;Yen HR;Luo W;Zeller K;Shimoda L;Topalian SL;Semenza GL;Dang CV;Pardoll DM;Pan F
通讯作者: Pan F
microRNA-326 水平升高通过靶向解整合素和金属蛋白酶来调节桥本甲状腺炎中的 IL-23/IL-23R/Th17 细胞轴 17
DOI: 10.1089/thy.2019.0552
发表时间: 2020-04-24
期刊: THYROID
影响因子: 6.6
作者:
Liu, Yongping;Cui, Xuejiao;Teng, Weiping
通讯作者: Teng, Weiping
DOI: 10.1073/pnas.1420419112
发表时间: 2015-03-03
影响因子: 11.1
作者:
Liu, Guangwei;Bi, Yujing;Yang, Ruifu
通讯作者: Yang, Ruifu